Cargando…
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
BACKGROUND: We initiated a prospective trial to identify transcriptional alterations associated with acquired chemotherapy resistance from pre- and post-biopsy samples from the same patient and uncover potential molecular pathways involved in treatment failure to help guide therapeutic alternatives....
Autores principales: | Kim, Hark Kyun, Choi, Il Ju, Kim, Chan Gyoo, Kim, Hee Sung, Oshima, Akira, Michalowski, Aleksandra, Green, Jeffrey E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041770/ https://www.ncbi.nlm.nih.gov/pubmed/21364753 http://dx.doi.org/10.1371/journal.pone.0016694 |
Ejemplares similares
-
Advanced Gastric Carcinoma Chemotherapy with Cisplatin, Mitomycin C, BCNU, and 5-Fluorouracil in Combination
por: Kim, Re Hwe, et al.
Publicado: (1987) -
miRNA signature associated with outcome of gastric cancer patients following chemotherapy
por: Kim, Chang Hee, et al.
Publicado: (2011) -
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection
por: Kim, Hark Kyun, et al.
Publicado: (2011) -
Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer
por: Kim, S T, et al.
Publicado: (2005) -
Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
por: Hwang, Junyl, et al.
Publicado: (2008)